Treatment of mucopolysaccharidosis type II (Hunter syndrome): a Delphi derived practice resource of the American College of Medical Genetics and Genomics (ACMG)

Diagnosis and follow-up of patients with Hunter syndrome in Spain

(2018) Luis González-Gutiérrez-Solana et al.   MEDICINE

Treatment of mucopolysaccharidosis type II (Hunter syndrome): results from a systematic evidence review

(2017) Linda A Bradley et al.   GENETICS IN MEDICINE

Survival in idursulfase-treated and untreated patients with mucopolysaccharidosis type II: data from the Hunter Outcome Survey (HOS)

(2017) Barbara K. Burton et al.   JOURNAL OF INHERITED METABOLIC DISEASE

Ten years of the Hunter Outcome Survey (HOS): insights, achievements, and lessons learned from a global patient registry

(2017) Joseph Muenzer et al.   Orphanet Journal of Rare Diseases

Is There a Consensus on Consensus Methodology? Descriptions and Recommendations for Future Consensus Research

(2016) Jane Waggoner et al.   ACADEMIC MEDICINE

Targeted approaches to induce immune tolerance for Pompe disease therapy

(2016) Phillip A Doerfler et al.   Molecular Therapy-Methods & Clinical Development

Structural Basis of Mucopolysaccharidosis Type II and Construction of a Database of Mutant Iduronate 2-Sulfatases

(2016) Seiji Saito et al.   PLoS One

A phase I/II study of intrathecal idursulfase-IT in children with severe mucopolysaccharidosis II

(2015) Joseph Muenzer et al.   GENETICS IN MEDICINE

Guidelines for diagnosis and treatment of Hunter Syndrome for clinicians in Latin America

(2014) Roberto Giugliani et al.   GENETICS AND MOLECULAR BIOLOGY

Defining consensus: A systematic review recommends methodologic criteria for reporting of Delphi studies

(2014) Ivan R. Diamond et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Long-term experience with enzyme replacement therapy (ERT) in MPS II patients with a severe phenotype: an international case series

(2014) Christina Lampe et al.   JOURNAL OF INHERITED METABOLIC DISEASE

Algorithm for the Early Diagnosis and Treatment of Patients with Cross Reactive Immunologic Material-Negative Classic Infantile Pompe Disease: A Step towards Improving the Efficacy of ERT

(2013) Suhrad G. Banugaria et al.   PLoS One

The role of enzyme replacement therapy in severe Hunter syndrome—an expert panel consensus

(2011) Joseph Muenzer et al.   EUROPEAN JOURNAL OF PEDIATRICS

Mucopolysaccharidosis type II: European recommendations for the diagnosis and multidisciplinary management of a rare disease

(2011) Maurizio Scarpa et al.   Orphanet Journal of Rare Diseases

Initial report from the Hunter Outcome Survey

(2009) J Edmond Wraith et al.   GENETICS IN MEDICINE

Multidisciplinary Management of Hunter Syndrome

(2009) J. Muenzer et al.   PEDIATRICS